Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer

Zachary A P Wintrob, Jeffrey P. Hammel, George K. Nimako, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu

Research output: Contribution to journalArticle

  • 2 Citations

Abstract

Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.

LanguageEnglish (US)
Pages459-468
Number of pages10
JournalData in Brief
Volume11
DOIs
StatePublished - Apr 1 2017

Fingerprint

incident
cancer
chronic illness
drug
time

Keywords

  • Breast cancer
  • Cancer outcomes
  • Cancer prognosis
  • Diabetes
  • EGF
  • FGF
  • Growth factor
  • HGF
  • Insulin secretagogue
  • PDGF
  • TGF
  • VEGF

ASJC Scopus subject areas

  • Education
  • General

Cite this

Wintrob, Z. A. P., Hammel, J. P., Nimako, G. K., Gaile, D. P., Forrest, A., & Ceacareanu, A. C. (2017). Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer. Data in Brief, 11, 459-468. DOI: 10.1016/j.dib.2017.02.038

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer. / Wintrob, Zachary A P; Hammel, Jeffrey P.; Nimako, George K.; Gaile, Dan P.; Forrest, Alan; Ceacareanu, Alice C.

In: Data in Brief, Vol. 11, 01.04.2017, p. 459-468.

Research output: Contribution to journalArticle

Wintrob ZAP, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer. Data in Brief. 2017 Apr 1;11:459-468. Available from, DOI: 10.1016/j.dib.2017.02.038
Wintrob, Zachary A P ; Hammel, Jeffrey P. ; Nimako, George K. ; Gaile, Dan P. ; Forrest, Alan ; Ceacareanu, Alice C./ Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer. In: Data in Brief. 2017 ; Vol. 11. pp. 459-468
@article{3f024b97ba7b430f84361cb8a4c4e26c,
title = "Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer",
abstract = "Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.",
keywords = "Breast cancer, Cancer outcomes, Cancer prognosis, Diabetes, EGF, FGF, Growth factor, HGF, Insulin secretagogue, PDGF, TGF, VEGF",
author = "Wintrob, {Zachary A P} and Hammel, {Jeffrey P.} and Nimako, {George K.} and Gaile, {Dan P.} and Alan Forrest and Ceacareanu, {Alice C.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.dib.2017.02.038",
language = "English (US)",
volume = "11",
pages = "459--468",
journal = "Data in Brief",
issn = "2352-3409",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer

AU - Wintrob,Zachary A P

AU - Hammel,Jeffrey P.

AU - Nimako,George K.

AU - Gaile,Dan P.

AU - Forrest,Alan

AU - Ceacareanu,Alice C.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.

AB - Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.

KW - Breast cancer

KW - Cancer outcomes

KW - Cancer prognosis

KW - Diabetes

KW - EGF

KW - FGF

KW - Growth factor

KW - HGF

KW - Insulin secretagogue

KW - PDGF

KW - TGF

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=85014361778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014361778&partnerID=8YFLogxK

U2 - 10.1016/j.dib.2017.02.038

DO - 10.1016/j.dib.2017.02.038

M3 - Article

VL - 11

SP - 459

EP - 468

JO - Data in Brief

T2 - Data in Brief

JF - Data in Brief

SN - 2352-3409

ER -